National Eczema Society has worked with other charities to create a Patient Charter for people living with atopic eczema, developed in collaboration with Sanofi. The new Patient Charter is being launched today (6 July 2023) in Westminster, where we are speaking to parliamentarians about the issues that matter to people with eczema.
UPDATE: National Eczema Society is very disappointed at the outcome of the recent NICE proposals to stop doctors prescribing bath emollients for children with eczema. These proposals have now been adopted.
National Eczema Society is excited to be co-funding the 2023 UK Dermatology Clinical Trials Network research awards. These are focusing on projects to improve care for people of colour.
Leading professional dermatology organisations and other charities have joined National Eczema Society in calling for clear potency labelling of steroid creams and ointments. We are asking the UK medicines regulator, the MHRA, to ensure pharmaceutical manufacturers include consistent and clear potency labelling on topical steroid tubes, packaging and patient information leaflets.
This free webinar features two informative talks from dermatology experts at the forefront of eczema research and practice.
The skin of many people with eczema improves in the spring and summer months, but some people’s eczema can be aggravated by pollen.
By subscribing you are agreeing to receive email newsletters from National Eczema Society. You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.
We use the Mailchimp platform to send out emails. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.
We use cookies to give you the best possible experience on our site. Find out more about our cookies.
